000 01443 a2200397 4500
005 20250517224724.0
264 0 _c20190131
008 201901s 0 0 eng d
022 _a1098-8823
024 7 _a10.1016/j.prostaglandins.2018.06.003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aPanagopoulos, Alexandros Theodoros
245 0 0 _aThe prostanoid pathway contains potential prognostic markers for glioblastoma.
_h[electronic resource]
260 _bProstaglandins & other lipid mediators
_c07 2018
300 _a52-62 p.
_bdigital
500 _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
650 0 4 _aAdult
650 0 4 _aBiomarkers, Tumor
_xmetabolism
650 0 4 _aDisease-Free Survival
650 0 4 _aFemale
650 0 4 _aGlioblastoma
_xmetabolism
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aNeoplasm Proteins
_xmetabolism
650 0 4 _aProstaglandins
_xmetabolism
650 0 4 _aSurvival Rate
700 1 _aGomes, Renata Nascimento
700 1 _aAlmeida, Fernando Gonçalves
700 1 _ada Costa Souza, Felipe
700 1 _aVeiga, José Carlos Esteves
700 1 _aNicolaou, Anna
700 1 _aColquhoun, Alison
773 0 _tProstaglandins & other lipid mediators
_gvol. 137
_gp. 52-62
856 4 0 _uhttps://doi.org/10.1016/j.prostaglandins.2018.06.003
_zAvailable from publisher's website
999 _c28593135
_d28593135